Pharmacy Podcast Network
Original podcast
Where to listenCopy share link
Mike Johnston, CEO of NPTA, Ashleigh Smith, NPTA- Director of Continuing Education, Benjamin Jolley, PharmD
4,524 words · 5 speakers
You are listening to the global network of podcasters dedicated to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
Welcome to CPHD Connect, the only weekly podcast specifically for pharmacy technicians. Join us as we dive into the hot topics, tough conversations, and industry trends affecting pharmacy technicians. In each episode, we connect you with industry leaders who want to help you expand your patient care, pharmacy practice, and professional advancement. Now here's your host, Mike Johnston, CPHD.
Welcome to CPHD Connect. I'm your host, Mike Johnston, and joining me today, as always, is my co-host, Ms. Ashley Smith.
I'm doing great, just getting ready for the holidays, staying busy as always, but I'm excited for this episode.
This is like a podcast day, too, where we are like recording four episodes back off the back. Yeah, it's gonna be a heck of a day. But our first one, which I'm really excited about for today is with Dr. Benjamin Jolly. And Dr. Jolly is a third-generation independent pharmacy operator and co-founder of Apex Pharmacy Consulting. He's been dedicated to pharmacy for over 20 years, working in nearly every role imaginable, from delivery driver to tech to pharmacist. And he is super passionate about pharmacy operations and a self-proclaimed drug pricing nerd,
which is gonna be a great fit because Ashley and I are also like data nerds. So that'll be fun. So yeah, we're looking forward to this. We're gonna dive into what's going on with independent pharmacy and PBM reforms. So Ben, welcome to the show. Thank you so much for joining us.
Of course, happy to be here.
So we always like to start off our episodes with just kind of a quick intro. So just tell us, obviously, multi-generational family in pharmacy, but tell us about how you got into pharmacy and how your family got into pharmacy.
Yeah, so I started working for my dad in two thousand four when I was just barely starting high school and I worked as a clerk. I ran the registers, I combined the patient prescription bags, I filed prescriptions. When I graduated high school, I became a pharmacy technician. I was a CPHT for a couple of years. Let's see, that would have been two thousand eight until when I started pharmacy school in two thousand fourteen. I enjoyed my work in the pharmacy, so I decided, you know, maybe I should make a career out of this. And so I, I went to pharmacy school in St. Louis. That's like how I personally got into
it. My grandpa started in the family business. He, he went to pharmacy school, starting in Idaho and then was in the inaugural class at the University of Utah, graduated from the University of Utah College of Pharmacy in nineteen fifty. He thought he wanted to be a professor of pharmacy and went to Seattle for a few months and then that did not work. He like tried for like three months and just, he was like, no, this is not for me. So he moved back to Salt Lake City. He met a pharmacist, Dr. King, well, Mr. King here in, in Salt Lake, worked for him for a couple of years. And then four years later, he opened Jolly's
Compounding Pharmacy, sorry, what is now Jolly's Compounding Pharmacy, what was then called King Jolly Rexall Drug. And he, so that was June seventh nineteen fifty-four. So this, this June, we turned seventy as a business. Oh, wow. Which is pretty darn cool. I'm, I'm pretty happy about it. I hope to keep us going for another thirty years. We'll see, get us to a hundred, but you know, we'll see how that goes. So far, so good. And my, he started in pharmacy in nineteen eighty. He also graduated from the University of Utah College of Pharmacy and has been the, what's the right word here? The biggest advocate for compounding pharmacy in the state of Utah for forty years. He's
trained like half of the people that operate their own compounding pharmacies now have passed our pharmacy as pharmacists or technicians. So.
We have a family legacy of like helping other folks as well. And I mean, since I became a pharmacist, I went and worked for dad when I graduated. As a pharmacist, I was actually a funny story. When I came back from St. Louis, I came home, middle of June of, this would have been 2018, right after I graduated in May. And dad has a staff meeting on, like, I got there Saturday night, went to church Sunday. Monday morning, we have a staff meeting and dad says, Benjamin is, this is Benjamin. He's in charge now. I'm going to Europe for two weeks on vacation. Have fun.
And so I went from being a student pharmacist to being a pharmacist who did not properly have a license yet, but in charge of a pharmacy over the course of a couple of weeks. And that was a bit of a baptism by fire. But then since then, we've had a lot more stable staff been able, and I've been able to help pharmacies all over the country to understand really stupid federal policy stuff. So that's where Apex Pharmacy Consulting came out of was I started helping pharmacies to understand direct and indirect remuneration when that was a thing and effective rates
and maximum allowable costs and all of these really financial terms that pharmacy school does not teach you anything about. But that really, really impacts the business of can you operate a pharmacy practice profitably today? And then I, I also took a job recently as a senior fellow for healthcare policy at the American Economic Liberties Project. So I talk a lot about healthcare policy in general, PBM reform in particular, because the way that our lived experience in pharmacy is so driven by these massive middle mecs
is just incredible. And, and it's frankly unfair. Like that, that I think is, is the core point that I've come to is that the way that The way that the market, that pharmacists and pharmacy technicians operate in is fundamentally unfair and tilted towards the biggest companies.
Yeah, absolutely. Before we jump into really diving into what's going on in the independent world, I know you've got four, four kids.
I do, yeah.
Is there an indication that we've got like a fourth generation coming?
Fingers crossed.
Yeah. Push it on your kid, but also how cool would that be?
Yeah.
Like four of them, but.
They have all said at some point, I want to be a pharmacist like dad when I grow up. But we'll see if that, that the oldest is, is 10, we'll see if that, you know, I want to be like my dad desire actually translates into, I want to go through all of the, all of the things to be a pharmacist, but we'll see. I can flip the coin, roll the dice four times.
Those are good odds.
Um, so what would you say are some of the biggest challenges that you're facing within the independent pharmacy space?
So to me, the, the biggest issue with, that, that faces small business pharmacies, independent pharmacies, and frankly pharmacy in general, is that the prices don't make sense. The way that pharmacies get paid for what we do in the pharmacy is, is the only word that properly describes it. Like the way I like to describe it as well is that if you're, if you think of yourself as a pharmacy rather than a technician who, you know, earns a wage or a pharmacist who might earn a salary or whatever, if you think of yourself as the business entity, every time you fill a prescription, you're basically going to Vegas and just pulling the slots.
And in Vegas, you know, the house always wins. In pharmacy, the PPM always wins.
Right.
But there's like, you pull the slots and most of the time you get nothing, right? Most of the time you you might lose money. And when you look at a pharmacy's like, just the cost that it is to pay technicians, to pay pharmacists, to pay the rent, something like seventy percent of prescriptions that pharmacies fill are sold below the cost to buy the drugs and pay the staff, just for the time that we spend working on on filling prescriptions, which is like crazy, right? Why would we sell prescriptions below that cost to acquire the product? Which like, even if you leave out, even if you say that technicians should work for free, pharmacists should work for free, something like thirty percent of prescriptions are are sold
below the pharmacy's cost to buy the drug.
Is absolutely insane, but it is the reality that we that we operate in. And then every once in a while, very rarely, but like, maybe once a day, maybe twice a day, you'll have one prescription where the pharmacy hits, gets triple sevens on on the slot machine. And that pays the staff for the day, that pays the rent for the day, and everyone's happy. But like, that's crazy. What, why do we pay below cost for most things? And then it's like, okay, if we hit the jackpot on one prescription, then we're we're in business for the day.
Does that happen in any other industry? I'm asking it rhetorically, partially, but.
Um, there are similar kinds of things in other industries. But and and every time that you see stuff like this, it's um, it's because there's a giant middleman somewhere who's manipulating the system. I mean, to some degree, like this same kind of, we're going to pay you variable pricing. It's not terribly dissimilar from working for Uber. It's not like it's not the same thing because there's not really the same jackpot thing. But but if you go take rides for Uber, like you're gonna get paid a little bit less than it costs you on a lot of things and you'll get paid a little bit more and you'll make it up in temps. If you work for and then they'll have these bonuses if you like do twenty rides or something.
If you go into um chicken farming, which don't go into chicken farming, but if you go into chicken farming.
Birds. I'm not going.
I have so many questions.
There's so i- in chicken farming, there's this concept of a tournament system where the the meat processor who buys the chickens from you um basically tells you everything about how to live your life. Like they say, put the chickens, they put the chicks in this much light, give them this kind of feed. And but like you're you're theoretically a small business that you own your chickens. But like you buy your chick, your chicks from like Tyson Foods and you sell your chicks to Tyson Foods. So like, are you really a an independent business? And they tell you how to do all of the things.
But then this tournament system is they will like pit all of the different chicken farmers in a region against each other and say whoever has the fattest chick chickens at the end gets like twenty percent more money. And everyone else gets just the base rate. And so you get like this this weird pricing dynamics where you get paid more if you're lucky, basically, because they also do like these experiments on you where they say use this lighting, use this feed, use this method, like they they tell you everything of how to run your place. But then if you get lucky and your chicks happen to it, they happen to have hit the right um experiment.
Then you get paid twenty percent more randomly and it doesn't feel like it's under your control. Um, which is, again, it's not the same thing, but it's like, again, giant middleman only purchaser, that's kind of a similar analogous type of situation and and thi- this is why I I. Took this job at Economic Liberties is that I started to observe that pharmacy has unique problems, but really every industry has some degree of this like giant company dominating everybody and telling everyone how to live their life and telling everyone this is the price and this is how things work. And like Ticketmaster is another great example of like giant company
that tells a arena venue how to operate and does all of this corrupt stuff to steal money away from the artists as well. No one likes Ticketmaster. They are, but they are very similar to in function to a pharmacy benefit manager of like coordinating all of the money flows in the background. Hopefully all that made sense.
Yeah. So, well, you've got these middlemen that are providing little to no actual value. Like there's no value creation in that process. It's just kind of absorbing all the money out of that process. And in pharmacy, they're taking it from both sides.
Yeah. I mean, yeah. So i- in the defense of PBMs, which is a weird phrase to say, but like, I think that if we're going to have a world where you have insurance pay for prescriptions, there has to be something like a PBM. It doesn't have to be named Express Scripts or CVS Caremark or OptumRx, but you have to have somebody making sure checks get paid. You have to have somebody making sure that people are actually eligible for benefits. You have to make, make sure someone, someone has to set a list of covered drugs. Someone has to set prior authorization criteria and approve them if you want to have a reasonable price. Right? And so we all hate them.
With good reason, but like something like this will exist in a world where there is third-party payment for prescriptions. To me, it's not a question of like, do they provide any value? I mean, connecting, making it so that a pharmacy can submit a bill for a prescription for like seventeen thousand different companies is a useful service. Like, in a world without a CVS, Caremark, I would have to like, figure out how to submit a bill to Rio Tinto, to JP Morgan Chase, and to Salt Lake City School District for my different customers. And like, the administrative complexity of doing that in a world where
there's not like some centralized system to do it, it seems insane. And so, probably most people would not bill insurance. It would just be, you know, patient pays for their drugs, which honestly is maybe the way it should be for most drugs. But that's, that's a broader, a broader question. But to me, like, the big idea that really, really bothers me about the way that pharmacy benefit managers operate today is that they are both managing other people's money, right? They are administering benefits on behalf of all these giant corporations that I name. And they're also a pharmacy. And the opportunities to suck money out of the system when you are in charge of managing other people's
money, and you're in charge of selling drugs, is, um, suggests like, to me, that's just too much. You shouldn't be able to be on both sides like that. I think there should be a wall between those. You should either be a PBM, where you're trying to take care of other people's money, make sure they're not spending too much on their drugs, or you're a pharmacy. If you're, if you as an entity are on both sides of that transaction, like, that means that you have this conflicted job of, I'm supposed to keep spending down, but also I'm supposed to keep spending up for drugs. I want to sell as many drugs as possible. And that's just not a, to me, like, society should just say, no, that's not
okay. You can't be on both sides of the transaction. So, I was really excited when Liz Warren introduced the Patients Before Monopolies Act that does exactly that.
More than 1,400 pharmacy technicians have now advanced their careers with BPTS, the Board of Pharmacy Technician Specialties, an independent initiative of the National Pharmacy Technician Association. With 15 specialized credentials and certificates available, including board certifications in sterile compounding, hazardous compounding, non-sterile compounding, and the CPHT Advanced Certification, the opportunities for growth are endless. Now, it's your turn. BPTS is dedicated to advancing 1,000 more pharmacy technician careers this year. And with our unmatched commitment to affordability and accessibility, investing in your future has never been easier.
At BPTS, we believe you should be earning more, not paying more. Visit bpts.org today and take your career to the next level.
It's a major conflict of interest. It's also with the patients. I remember years ago, kind of when, you remember when CVS made the big announcement, no longer going to sell tobacco, right? Like, before then, every pharmacy, you know, that's where they were making tons of money, was on all this cigarettes and stuff they were selling. And so CVS is like, oh, you know, they made the big PR piece and tried to make it about their healthy initiative, and it's about their patients' health. And then meanwhile, like, 90 days later, their PBM changed the rules and told other patients, "Yeah, you can fill your scripts anywhere, but if you fill it at a pharmacy that sells tobacco, your copay is going up."
Like, okay, so you weren't doing any of that about the actual tobacco products. You're siphoning patients and punishing them not to go there. How did we? Well, I think it's probably like a multi-part series to say, how did we get here? But what are some tangible steps on how do we get out of here? Or at least, what can the independents be doing to address this right now?
Yeah, that's a good question. So, I mean, to your point, that to me is is one of the like, big harms to to patients from this vertical integration where where your PBM is your pharmacy is that suddenly pharmacies don't have to earn your business by being good at being pharmacies and being good at getting your prescriptions to you quickly and being kind and being reasonable human beings. You have to go to CBS and like, i- if your benefit design says you you pay 100% co-insurance if you go to a competitor or you pay a $5 copay at CBS, then effectively you've been bribed
with your own money because it's your premium money that doing this, right? Then effectively you have to use CBS to get your prescriptions. And so then CBS can be like, as a corporate entity can cut their staffing so that they don't fill prescriptions in a timely manner. They can abuse their staff because because then the like, who cares if our staff is happy and is nice to our customers? The customers have to come here. Shut up.
Like, that's one of the big harms that I see in this as well. There's, there's a ton of other ones where like, you can pay yourself more and pay your competitors less. You can force people to use you. And to me, it's just a step too far and we should just make it illegal. You can't do both. And so, and I think the same thing applies to being a doctor's office and being an insurance company. I don't think you should be both either. UnitedHealthcare does that or none. They have like, 10% of all the physicians in the country work for UnitedHealthcare now for their Optum division, I should say. And that to me is also like, really sketchy for the same reasons and should also be illegal. But how do we get out of this?
So I guess one is like, you can contact your congressman and say, hey, can you sign on as a co-sponsor for the Patients Before Monopole Act? There's also some other legislation that
Helps with some of the pricing stuff that I was talking about. The Pharmacists Fight Back Act is currently, in the current Congress, it's H R 9096. And it says that inside of the Medicare space, Medicaid space, TRICARE, federal employees, and hopefully the Affordable Care Act. Basically, if the government pays for your prescriptions in some way, then the government should be regulating those prices and say, no, you can't do this slot machine style thing. It would say you have to pay pharmacies what the drugs cost on average and what the staff costs on average. So we'll just pay the pharmacy on that basis, which is how Medicaid, right now, Medicaid
fee-for-service pays pharmacies on this basis. You take the average cost of the drug across pharmacies. You take the average cost to fulfill a prescription based on the overhead, based on the staff, whatever, and that's the price. And so you don't see situations where pharmacies lose their shirt on a couple of prescriptions and then they make a ton of money on a very small number of prescriptions. In Medicaid, you see just the pharmacy makes like $12 every time they fulfill a prescription before you account for staff and overhead. And that's about what it costs to operate a pharmacy is about $12 a prescription. And so it's fair and it's also very predictable.
And you know, like you know what what the pharmacy is going to get paid in advance. And so it makes it so that a pharmacy can plan, can budget for staff, so on and so forth. So that to me is a really important piece of legislation that I hope goes somewhere.
So I'm definitely gonna, we're gonna watch you back so we can dive into this further because it's fascinating. But just on the whole concept of cost, can you help me wrap my head around like, why are there so many different versions of cost? Like an average wholesale, you know, they're all made up and fake and you're doing rebates on this side and discounts. Like, can we just get down to like invoice costs?
I mean, that's a, I love, I love the description that it's all BS. It is. So it all comes out of just. Various market players trying to manipulate the market is why we have so many different prices. To some degree, this is this is normal, right? Like, if you go to a car dealership, they've got their sticker price, and then they have what they actually paid, right? And there's going to be a delta between those, and that's that's normal. When you're in a when you're in a multi-tiered distribution model, it's totally normal to have the price for the for the vendor, and then the price for the final customer, and have those be different numbers.
But there are like fourteen different metrics in pharmacy, because there are like fourteen different transactions that occur around every single prescription dispense, which we don't see inside of a pharmacy. But like, when you think about it, when you think about it globally, like, the pharmacy, when you fill a prescription, what what has happened here is that the manufacturer has sold a drug to a wholesaler, who then sold that drug to a pharmacy, who then submitted a claim to a PBM, who then came up with their own price to reimburse the pharmacy, and then split that price into what they will pay versus what the patient will pay. So you've got the copay, you've got that.
And then the PBM then submits an invoice to the insurer, which might be a different price than they paid the pharmacy. And then they might invoice the manufacturer for a rebate. And but maybe they won't, because maybe the pharmacy is a 340B covered entity owned pharmacy. And so they've already paid the rebate in advance by selling the drug for a much, much lower invoice price to the pharmacy. And so, and honestly, this all originates in choices that the federal government has made over the last forty years. They wanted to have 340B clinics subsidized.
They wanted to have drugs be less expensive, so we built the Medicaid Drug Rebate Program. And out of that comes all of these other rebates. And it's it feels like a complete mess, but it was intentionally, it's a series of intentional choices to use drugs to subsidize everything else in in the healthcare ecosystem, which is really annoying.
Well, Yeah, we're definitely going to have to have you back to dive deeper into all of this. This is fascinating. And then, and we didn't even get to the fact that two years, they'll do all of that. And then two years later, they'll send you an audit to do a crawl back if you don't have a signature stored on every piece of that journey.
Yeah. And if you're an independent, they audit you. If you're a chain, maybe they audit you. If you look at Mississippi Board of Pharmacy, they did an audit of OptumRx recently that I highly recommend reading. And it found that of the 26 audits that OptumRx performed in 2022, one of them was at a chain pharmacy. All of the rest were independent pharmacies.
Wow.
So, think about that for a minute. And then there's other, there's other stuff in that audit as well. Highly recommended reading for anybody who cares.
Well, if you're not already, be sure and connect with Dr. Benjamin Jolly on LinkedIn. He writes a super interesting newsletter on Substack. You can follow him there, connect with him to keep up to date with everything that he's putting out. Dr. Jolly, any final comments before we wrap this, this episode today?
No, it's been a pleasure to be with you and I look forward to talk to you two again.
Yes, thank you.
Thanks so much, Ashley and Mike.
Well, thanks for tuning into today's episode. We hope you found it both informative and inspiring. For link, show notes and resources from today's episode, visit cphtconnect.com. We'd love to hear from you. So send us your feedback, questions, stories, or show ideas to podcast@cpht.org. We appreciate your support and look forward to having you join us again next week as we chat with another amazing pharmacy professional and hear about their career journey. Thanks so much for listening.
Thank you for listening to this week's episode of CPHT Connect. Be sure to subscribe and review the show on your favorite podcast platform. For additional resources, show notes, or to connect with this week's guest, go to cphtconnect.com. And finally, we'd love to hear from you directly, your feedback, suggestions, questions, or stories. So drop us a note at podcast@cphtconnect.com.
Page updated November 15, 2026 · transcript and summary are machine-generated